Although the use of stimulants continues to increase in all age groups in the United States,1 an important debate has emerged in the last 2 years about how effective stimulants are for treating attention-deficit/hyperactivity disorder (ADHD). For some investigators, the main message in the literature is clear: the quality of evidence from randomized clinical trials on the efficacy of stimulants is poor.2 For others, the problem is in the meta-analysis from which these conclusions were taken.3
Rohde LA. Efficacy of Stimulants Beyond Treatment of Core Symptoms of Attention-Deficit/Hyperactivity Disorder. JAMA Psychiatry. 2017;74(8):822–823. doi:10.1001/jamapsychiatry.2017.1423
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: